Gex2SGen: designing drug-like molecules from desired gene expression signatures

D Das, B Chakrabarty, R Srinivasan… - Journal of Chemical …, 2023 - ACS Publications
Drug-induced gene expression profiling provides a lot of useful information covering various
aspects of drug discovery and development. Most importantly, this knowledge can be used …

[HTML][HTML] Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer

KM Jungles, EA Holcomb, AN Pearson… - Frontiers in …, 2022 - frontiersin.org
Breast cancer is the most prevalent non-skin cancer diagnosed in females and developing
novel therapeutic strategies to improve patient outcomes is crucial. The immune system …

[HTML][HTML] Dual anticancer and antibacterial properties of silica-based theranostic nanomaterials functionalized with coumarin343, folic acid and a cytotoxic organotin (IV …

M Ugalde-Arbizu, JJ Aguilera-Correa… - Pharmaceutics, 2023 - mdpi.com
Five different silica nanoparticles functionalized with vitamin B12, a derivative of coumarin
found in green plants and a minimum content of an organotin (IV) fragment (1-MSN-Sn, 2 …

[HTML][HTML] Treatment strategies for residual disease following neoadjuvant chemotherapy in patients with early-stage breast cancer

H Abdel-Razeq, H Khalil, HI Assi, TB Dargham - Current Oncology, 2022 - mdpi.com
Breast cancer continues to be the most diagnosed cancer among women worldwide.
Neoadjuvant chemotherapy is the standard of care for breast cancer patients with locally …

[HTML][HTML] Predictive value of PD-L1 expression to the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer: A systematic review and meta …

Y Qi, X Yan, C Wang, H Cao, G Liu - Frontiers in Pharmacology, 2022 - frontiersin.org
Background: Immune checkpoint inhibitors (ICIs) have been an emerging treatment strategy
for advanced triple-negative breast cancer (TNBC). Some studies have shown that high …

EGFR/Notch antagonists enhance the response to inhibitors of the PI3K-Akt pathway by decreasing tumor-initiating cell frequency

W Fu, C Lei, Y Yu, S Liu, T Li, F Lin, X Fan, Y Shen… - Clinical Cancer …, 2019 - AACR
Abstract Purpose: Both EGFR and PI3K-Akt signaling pathways have been used as
therapeutically actionable targets, but resistance is frequently reported. In this report, we …

Calorie restriction and breast cancer treatment: A mini-review

MF Isaac-Lam, KM DeMichael - Journal of Molecular Medicine, 2022 - Springer
Calorie restriction (CR), referred to as a reduction in dietary calorie intake without
malnutrition, has been demonstrated to be a safe way to extend longevity of yeast, worms …

[HTML][HTML] Comprehensive analysis of PTPN gene family revealing PTPN7 as a novel biomarker for immuno-hot tumors in breast cancer

F Wang, X Wang, L Liu, S Deng, W Ji, Y Liu… - Frontiers in …, 2022 - frontiersin.org
Background: The non-receptor protein tyrosine phosphatase (PTPN) gene family has been
considered to be involved in the oncogenesis and development of multiple cancers …

Ex Vivo Evaluation of Combination Immunotherapy Using Tumor‐Microenvironment‐on‐Chip

HY Mu, CM Lin, LA Chu, YH Lin, J Li… - Advanced …, 2024 - Wiley Online Library
Combination immunotherapy has emerged as a promising strategy to address the
challenges associated with immune checkpoint inhibitor (ICI) therapy in breast cancer. The …

[HTML][HTML] Functionalized siRNA-chitosan nanoformulations promote triple-negative breast cancer cell death via blocking the miRNA-21/AKT/ERK signaling axis: in …

SA Abdulmalek, AM Saleh, YR Shahin… - Naunyn-Schmiedeberg's …, 2024 - Springer
Oncogenic microRNA (miRNA), especially miRNA-21 upregulation in triple-negative breast
cancer (TNBC), suggests a new class of therapeutic targets. In this study, we aimed to create …